Next Article in Journal
Proteomics Unveils Post-Mortem Changes in Beef Muscle Proteins and Provides Insight into Variations in Meat Quality Traits of Crossbred Young Steers and Heifers Raised in Feedlot
Next Article in Special Issue
Cathepsin S Inhibition Suppresses Experimental Systemic Lupus Erythematosus-Associated Pulmonary Arterial Remodeling
Previous Article in Journal
Radiation as a Tool against Neurodegeneration—A Potential Treatment for Amyloidosis in the Central Nervous System
Previous Article in Special Issue
Altered Circulating Follicular T Helper Cell Subsets and Follicular T Regulatory Cells Are Indicators of a Derailed B Cell Response in Lupus, Which Could Be Modified by Targeting IL-21R
 
 
Review
Peer-Review Record

Understanding Ocular Findings and Manifestations of Systemic Lupus Erythematosus: Update Review of the Literature

Int. J. Mol. Sci. 2022, 23(20), 12264; https://doi.org/10.3390/ijms232012264
by Wojciech Luboń 1,2,*, Małgorzata Luboń 1,2, Przemysław Kotyla 3 and Ewa Mrukwa-Kominek 1,2
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Int. J. Mol. Sci. 2022, 23(20), 12264; https://doi.org/10.3390/ijms232012264
Submission received: 23 August 2022 / Revised: 11 October 2022 / Accepted: 12 October 2022 / Published: 14 October 2022

Round 1

Reviewer 1 Report

1/References to be improved : 

-Long paragraph without references

-Too old or not the most relevant references

 

2/Several phrases not really useful such as in the introduction of the paragraphs. Try to go straight to the point.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Reviewer 2 Report

Authors have summarized and updated the literature regarding ocular manifestations of systemic lupus erythematosus which is appreciable, however, there are well written reviews earlier in similar line. But since, this is an update review of literature, it is advisable to authors if they can include recent clinical case studies with regard to each ocular manifestation.

In addition, authors can also include a table or a figure to summarize various complications associated with each ocular manifestation for clear understanding.

Since authors have mentioned that various systemic drugs used for SLE causes ocular complications, a detailed subjective opinion can be mentioned based on the clinical case studies reported on its prevention and also for treating ocular complications.

It would be of additional value if authors could include images of various ocular complications as they have already mentioned about their identification.

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The authors can add references to the newly added table. 

Author Response

Please see the attachment.

Author Response File: Author Response.pdf

Back to TopTop